There is growing need for a safe, efficient, specific and non-pathogenic means for delivery of
gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented …

Background Successful mass vaccination programmes are public health achievements of
the contemporary world. While pharmaceutical companies are actively developing new …

The outbreaks of infectious diseases that spread across countries have generally existed for
centuries. An example is the occurrence of the COVID-19 pandemic in 2020, which led to …

The COVID-19 pandemic has evidenced the chronic inequality that exists between
populations and communities as regards global healthcare. Vaccination, an appropriate tool …

Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to
recognise the full energy, environmental, economic and social equity (4E) impacts of the …

The main purpose of this review is to present justification for the urgent need to implement
specific prophylaxis of invasive Staphylococcus aureus infections. We emphasize the …

mRNA is like Hermes, delivering the genetic code to cellular construction sites, so it has long
been of interest, but only to a small group of scientists, and only demonstrating its …

Effective vaccine development for global outbreaks, such as the coronavirus disease 2019
(COVID-19), has been successful in the short run. However, the currently available vaccines …

Cytomegalovirus (CMV) is the most common infectious cause of congenital malformation
and a leading cause of developmental disabilities such as sensorineural hearing loss …

Introduction Microneedles are emerging as a promising technology for vaccine delivery, with
numerous advantages over traditional needle and syringe methods. Preclinical studies have …